{
    "startDate": "2018-01-01",
    "endDate": "2018-03-31",
    "year": "2018",
    "quarter": "Q1",
    "symbol": "OXGN",
    "data": {
        "bs": [
            {
                "label": "Other Assets, Noncurrent",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 33000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 437000
            },
            {
                "label": "Cash and Cash Equivalents, at Carrying Value",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 233000
            },
            {
                "label": "Prepaid Expense and Other Assets, Current",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 171000
            },
            {
                "label": "Assets, Current",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 404000
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Liabilities and Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 437000
            },
            {
                "label": "Accounts Payable, Current",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1164000
            },
            {
                "label": "Accrued Employee Benefits, Current",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Accrued Clinical Trial Expenses",
                "concept": "oxgn:AccruedClinicalTrialExpenses",
                "unit": "usd",
                "value": 90000
            },
            {
                "label": "Other Accrued Liabilities, Current",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 247000
            },
            {
                "label": "Liabilities, Current",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 1524000
            },
            {
                "label": "Preferred Stock, Value, Issued",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common Stock, Value, Issued",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 265000
            },
            {
                "label": "Additional Paid in Capital, Common Stock",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 291717000
            },
            {
                "label": "Retained Earnings (Accumulated Deficit)",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -293069000
            },
            {
                "label": "Stockholders' Equity Attributable to Parent",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -1087000
            }
        ],
        "cf": [
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Share-based Compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 184000
            },
            {
                "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 149000
            },
            {
                "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -125000
            },
            {
                "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -882000
            },
            {
                "label": "Net Income (Loss) Attributable to Parent",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -794000
            },
            {
                "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -882000
            }
        ],
        "ic": [
            {
                "label": "Operating Income (Loss)",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -795000
            },
            {
                "label": "Investment Income, Interest",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Net Income (Loss) Attributable to Parent",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -794000
            },
            {
                "label": "Earnings Per Share, Basic and Diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.03
            },
            {
                "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 26545000
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 225000
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 570000
            },
            {
                "label": "Operating Expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 795000
            }
        ]
    }
}